| Vaccination of melanoma patients with peptide-or tumorlysate-pulsed dendritic cells FO Nestle, S Alijagic, M Gilliet, Y Sun, S Grabbe, R Dummer, G Burg, ... Nature medicine 4 (3), 328-332, 1998 | 3914 | 1998 |
| Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer U Sahin, E Derhovanessian, M Miller, BP Kloke, P Simon, M Löwer, ... Nature 547 (7662), 222-226, 2017 | 2433 | 2017 |
| Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy LM Kranz, M Diken, H Haas, S Kreiter, C Loquai, KC Reuter, M Meng, ... Nature 534 (7607), 396-401, 2016 | 1712 | 2016 |
| Influence of pH on wound-healing: a new perspective for wound-therapy? LA Schneider, A Korber, S Grabbe, J Dissemond Archives of dermatological research 298 (9), 413-420, 2007 | 1175 | 2007 |
| An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma U Sahin, P Oehm, E Derhovanessian, RA Jabulowsky, M Vormehr, ... Nature 585 (7823), 107-112, 2020 | 812 | 2020 |
| Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma D Liu, B Schilling, D Liu, A Sucker, E Livingstone, L Jerby-Arnon, ... Nature medicine 25 (12), 1916-1927, 2019 | 776 | 2019 |
| Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide J Hosoi, GF Murphy, CL Egan, EA Lerner, S Grabbe, A Asahina, ... Nature 363 (6425), 159-163, 1993 | 774 | 1993 |
| Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable … A Hauschild, SS Agarwala, U Trefzer, D Hogg, C Robert, P Hersey, ... Journal of Clinical Oncology 27 (17), 2823-2830, 2009 | 702 | 2009 |
| Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity S Grabbe, T Schwarz Immunology today 19 (1), 37-44, 1998 | 677 | 1998 |
| Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III … D Schadendorf, S Ugurel, B Schuler-Thurner, FO Nestle, A Enk, ... Annals of Oncology 17 (4), 563-570, 2006 | 614 | 2006 |
| Lysozyme M–positive monocytes mediate angiotensin II–induced arterial hypertension and vascular dysfunction P Wenzel, M Knorr, S Kossmann, J Stratmann, M Hausding, ... Circulation 124 (12), 1370-1381, 2011 | 554 | 2011 |
| Antigen presentation in extracellular matrix: interactions of T cells with dendritic cells are dynamic, short lived, and sequential M Gunzer, A Schäfer, S Borgmann, S Grabbe, KS Zänker, EB Bröcker, ... Immunity 13 (3), 323-332, 2000 | 551 | 2000 |
| Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage MS Labeur, B Roters, B Pers, A Mehling, TA Luger, T Schwarz, S Grabbe The Journal of Immunology 162 (1), 168-175, 1999 | 519 | 1999 |
| The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network CJ Voskens, SM Goldinger, C Loquai, C Robert, KC Kaehler, C Berking, ... PloS one 8 (1), e53745, 2013 | 503 | 2013 |
| Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells K Loser, A Mehling, S Loeser, J Apelt, A Kuhn, S Grabbe, T Schwarz, ... Nature medicine 12 (12), 1372-1379, 2006 | 474 | 2006 |
| Spontaneous skin ulceration and defective T cell function in CD18 null mice K Scharffetter-Kochanek, H Lu, K Norman, N Van Nood, F Munoz, ... The Journal of experimental medicine 188 (1), 119-131, 1998 | 472 | 1998 |
| Interleukin-1 beta—a friend or foe in malignancies? R Bent, L Moll, S Grabbe, M Bros International journal of molecular sciences 19 (8), 2155, 2018 | 462 | 2018 |
| Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy? S Grabbe, S Beissert, T Schwarz, RD Granstein Immunology today 16 (3), 117-121, 1995 | 415 | 1995 |
| Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis T Honda, G Egawa, S Grabbe, K Kabashima Journal of Investigative Dermatology 133 (2), 303-315, 2013 | 398 | 2013 |
| Tumor antigen presentation by murine epidermal cells. S Grabbe, S Bruvers, RL Gallo, TL Knisely, R Nazareno, RD Granstein Journal of immunology (Baltimore, Md.: 1950) 146 (10), 3656-3661, 1991 | 322 | 1991 |
Maximilian HaistPostdoctoral Fellow, Garry P. Nolan Lab, Stanford University確認したメール アドレス: stanford.edu